-
Systemic therapy for advanced pheochromocytoma and paraganglioma: real-world evidence from a single-center cohor
Author: Liang, Yun; Xu, Junyan; Huang, Dan; Tang, Wei; Sun, Zhichen; Chen, Luohai; Chen, Jie
Journal: ENDOCRINE-RELATED CANCER. 2026; Vol. 33, Issue 2, pp. -. DOI: 10.1530/ERC-25-0437
-
Adrenocortical cell and macrophage heterogeneity at single-cell spatial resolution in KCNJ5-mutant aldosterone-producing adenoma
Author: He, Furong; Hu, Jinbo; Zeng, Qinglian; Wang, Xiao; Li, Hongji; Li, Ruolin; Li, Jiayu; Li, Junlong; Xiong, Yunjie; Yin, Juan; Liu, Yunyan; Peng, Chuan; Song, Ying; Xu, Yong; Huang, Wei; Li, Qifu; Ma, Linqiang; Yang, Shumin
Journal: ENDOCRINE-RELATED CANCER. 2026; Vol. 33, Issue 2, pp. -. DOI: 10.1530/ERC-25-0246
-
Lenvatinib and everolimus synergistically inhibit neuroendocrine neoplasms by upregulating ITGB4 expressio
Author: Xie, Liping; Bo, Yaning; Yang, Mei; Gui, Qi; Tao, Min
Journal: ENDOCRINE-RELATED CANCER. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1530/ERC-25-0233
-
Defining the ATA-2025 'consider RAIT' zone in older patients with N1b PT
Author: Wang, Ziqiang; Song, Xue; Wang, Tingting; Xie, Yangyang; Du, Qiwei; Zhang, Weijun; Liu, Nian; Li, Rongguo; He, Jiawei
Journal: ENDOCRINE-RELATED CANCER. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1530/ERC-25-0420
